• Sohini Chakrabarti Department of Genetics, Vivekananda Institute of Medical Sciences, Ramakrishna Mission Seva Pratishthan
  • Debasish Maji Department of Endocrinology, Vivekananda Institute of Medical Sciences, Ramakrishna Mission Seva Pratishthan
  • Madhusnata De Department of Genetics, Vivekananda Institute of Medical Sciences, Ramakrishna Mission Seva Pratishthan


Thyroid epithelial cells produce moderate amounts of Reactive Oxygen Species (ROS) under normal conditions that are physiologically required for the synthesis of thyroid hormones. However, in case of a diseased thyroid gland they may be produced in amounts much higher than normal. This excess production of ROS can cause an oxidant/antioxidant imbalance resulting in oxidative stress and damage of cells. The human antioxidant defense mechanism consists of various enzymatic and non-enzymatic components which are responsible for the quenching of ROS.The present study is aimed at comparing the activity of antioxidant enzyme- Superoxide Dismutase (SOD) from blood of patients with benign and malignant thyroid nodules of non-toxic group and healthy controls in order to evaluate the possibility of presence of excess oxidative stress and its role in development of thyroid cancer.


Oxidative stress, Superoxide dismutase, Thyroid cancer


Download data is not yet available.


Albores-Saavedra, J., Henson, D. E., Glazer, E. & Schwartz , A. M. (2007). Changing patterns in the

incidence and survival of thyroid cancer with follicular phenotype—papillary, follicular, and

anaplastic: a morphological and epidemiological study. Endocrine Pathology, 18(1), pp 1–7.

Bankson, D.D., Kestin, M. & Rifai, N. (1993). Role of free radicals in cancer and atherosclerosis. Clinics in Laboratory Medicine, 13(2), pp 463-80.

Barroeta, J.E., Wang, H., Shiina, N., Gupta, P.K., Livolsi, V.A. & Baloch, Z.W. (2006). Is fine-needle aspiration (FNA) of multiple thyroid nodules justified? Endocrine Pathology, 17(1), pp 61–5.

Davies, L. & Welch, H. G. (2006). Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA, 295(18), pp 2164–2167.

Durak, I., Bayram, F., Kavutcu, M., Canbolat, O. & Öztürk, S. (1996). Impaired enzymatic antioxidant defense mechanism in cancerous human thyroid tissues. Journal of Endocrinological Investigation, 19(5), pp 312-5

Felt, V., Cerný, K., Klímová, H., Kŕemenová, J. & Rehák, F. (1976). Enzyme changes in thyroid tissue

with reference to thyroid cancer. Acta Universitatis Carolinae Medica (Praha), 22(7-8), pp 435-42.

Fujita, T. (2002). Formation and Removal of Reactive Oxygen Species, Lipid Peroxides and Free Radicals, and Their Biological Effects. Yakugaku Zasshi - Journal of the Pharmaceutical Society of

Japan, 122(3), pp 203-218.

Gharib H, Papini E, Paschke R, Duick DS, Hegedus L, Vitti, P., AACE/AME/ETA Task Force on Thyroid

Nodules (2010). American Association of Clinical Endocrinologists, Associazione Medicie Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocrine Practice, 16(3), pp 468-75

Hodgson, N. C., Button, J. & Solorzano, C.C. (2004).Thyroid cancer: is the incidence still increasing? Annals of Surgical Oncology, 11(12), pp 1093–1097.

Oberley, L.W. & Oberley, T.D. (1984). The role of superoxide dismutase and gene amplification in

carcinogenesis. Journal of Theoretical Biology, 106(3), pp 403-422.

Marklund, S. & Marklund, G. (1974). Involvement of the Superoxide Anion Radical in the Autoxidation

of Pyrogallol and a Convenient Assay for Superoxide Dismutase. European Journal of Biochemistry, 47(3), pp 469–474.

Polyzos, S.A., Kita, M. & Avramidis, A. (2007) Thyroid nodules-Stepwose diagnosis and management. Hormones (Athens), 6(2), pp 101–119

Poncin, S., Van Eeckoudt, S., Humblet, K., Colin, I.M. & Gérard, A.C. (2010). Oxidative stress: a required condition for thyroid cell proliferation. The American journal of pathology, 176(3), pp 1355-63.

Sadani, G.R. & Nadkarni, G.D. (1996). Role of tissue antioxidant defence in thyroid cancers. Cancer

Letters, 109(1-2), pp 231-235.

Yanagawa, T., Ishikawa, T., Ishii, T., Tabuchi, K., Iwasa, S., Bannai, S., Omura, K., Suzuki, H. &

Yoshida, H. (1999). Peroxiredoxin I expression in human thyroid tumors. Cancer Letters,145(1-2), pp 127-32.




How to Cite

Sohini Chakrabarti, Debasish Maji, & Madhusnata De. (2018). EVALUATION OF ROLE OF SUPEROXIDE DISMUTASE IN NON-TOXIC THYROID NODULES . Malaysian Journal of Medical Research (MJMR), 2(1), 49-51. Retrieved from https://ejournal.lucp.net/index.php/mjmr/article/view/248